Metabolic & Weight
Semaglutide
A well-known GLP-1 receptor agonist studied extensively for appetite regulation, blood-sugar control and weight management.
What it is
Semaglutide is a long-acting GLP-1 receptor agonist — the compound that brought this entire class into the mainstream. It mimics the incretin hormone GLP-1, which the gut releases after eating.
How it's thought to work
By activating GLP-1 receptors, semaglutide enhances satiety, slows gastric emptying and supports insulin release when glucose is high. The net effect in research is reduced appetite and steadier blood sugar.
Potential health benefits
Studied for:
- Weight management through appetite reduction.
- Glycaemic control.
- Broader cardiometabolic markers in large trials.
What the research says
Semaglutide has one of the deepest clinical evidence bases of any peptide discussed here, with extensive human trial data on weight and metabolic endpoints. Gastrointestinal side effects are the most commonly reported.
Considerations
A research compound for general use here. Because it strongly affects appetite and digestion, qualified medical oversight is recommended.
Recommended suppliers
Where to find research-grade Semaglutide
If you're sourcing Semaglutide for research, we recommend Pharma Tides— independently tested, >99% HPLC purity, with a Certificate of Analysis on every batch.
View Semaglutide at Pharma Tides